Dallah Healthcare's revenues grew by 21.7% in the first quarter of 2026
recorded Dallah Healthcare significant revenue growth during the first quarter of 2026, reflecting the strength of its operational and expansion strategy in the Saudi Arabian healthcare market. This positive performance was driven by a notable increase in patient visits to the group's hospitals, underscoring patients' confidence in the quality of services provided.
The journey of development and leadership in the healthcare sector
Dallah Healthcare Company was established in 1995 and has since been committed to providing comprehensive, high-quality healthcare services. In a strategic move to strengthen its position, the company was listed on the Saudi Stock Exchange (Tadawul) in 2012. Today, the company plays a pivotal role in supporting the goals of Saudi Vision 2030, which aims to enhance private sector participation in healthcare delivery and improve the quality of life for citizens and residents. This long history of excellence has made Dallah a trusted name and enabled it to continuously expand into a wide network of hospitals and specialized clinics serving millions of patients annually.
Details of Dallah Healthcare's revenue growth for the first quarter of 2026
Financial results showed that Dallah Healthcare's revenues increased by 21.7% to reach SAR 1,013.26 million, compared to SAR 832.75 million for the same quarter of the previous year, an increase of SAR 180.51 million. This strong growth was directly supported by a 27.5% surge in patient visits, reaching 936,000 visits compared to 734,000 visits last year. This growth is attributed to operational expansion, particularly following the acquisition of Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital, which broadened the geographical reach of the group's services.
Net profit analysis and seasonal challenges
Despite revenue growth, the company's net profit declined by 45.7% to SAR 84.52 million. This decrease is primarily attributed to a one-off event in the corresponding quarter of 2025, where the company recorded a SAR 51 million gain from its investment in a real estate fund. Additionally, financing costs and operating expenses increased following the consolidation of the newly acquired hospitals' results. However, gross profit showed an improvement of SAR 36 million, underscoring the efficiency of underlying operational performance despite the seasonal challenges of Eid al-Fitr and the start of the school year.
The economic and local impact of the group's expansions
This rapid growth in the company's operations is of paramount importance both locally and regionally. Locally, the ongoing expansions are creating thousands of job opportunities for medical and administrative staff and increasing the healthcare sector's capacity to meet the growing demand across the Kingdom. Regionally, the success of Dallah Healthcare's model enhances the attractiveness of the Saudi market for healthcare investments and underscores the ability of listed Saudi companies to build large, sustainable healthcare entities that compete with international standards and bolster the strength of the national economy.
Future vision and board statements
Commenting on these results, Eng. Tariq Al-Qasabi, Chairman of the Board of Directors of Dallah Healthcare Company, confirmed that net profit is fully in line with the projections outlined in the company's 2026 budget. He commended the group's ability to exceed one billion riyals in quarterly revenue, reflecting its resilient performance and strong operational base. Al-Qasabi expressed optimism for the future, highlighting upcoming expansion projects such as Al-Ared Hospital north of Riyadh, and investments in digitalization projects aimed at improving patient experience and enhancing operational efficiency.
Contact information for investors
Dallah Healthcare is committed to transparency and continuous communication with its shareholders. Those interested can access the financial results documents on the company's investor relations website or contact the investor relations team directly for further details.
